Log in
Enquire now

List of Mimetogen Pharmaceuticals patents

List of Mimetogen Pharmaceuticals patents
List of Tris Pharma patents
List of Gilead Sciences patents
List of Appian patents
List of funding rounds for WorkFusion, Inc.
List of awards received by Jane the Virgin
Patents where
Current Assignee
Name
is
‌
Mimetogen Pharmaceuticals
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 9707267 Beta-turn peptidomimetic cyclic compounds for treating dry eye

Patent 9707267 was granted and assigned to Mimetogen Pharmaceuticals on July, 2017 by the United States Patent and Trademark Office.

‌
Mimetogen Pharmaceuticals
‌
Mimetogen Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
9707267
July 18, 2017
‌
US Patent 11078234 Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic salts

Patent 11078234 was granted and assigned to Mimetogen Pharmaceuticals on August, 2021 by the United States Patent and Trademark Office.

‌
Mimetogen Pharmaceuticals
‌
Mimetogen Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
11078234
August 3, 2021
‌
US Patent 10125165 Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic salts

Patent 10125165 was granted and assigned to Mimetogen Pharmaceuticals on November, 2018 by the United States Patent and Trademark Office.

‌
Mimetogen Pharmaceuticals
‌
Mimetogen Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
10125165
November 13, 2018
‌
US Patent 8653036 Methods of treating retinitis pigmentosa

Patent 8653036 was granted and assigned to Mimetogen Pharmaceuticals on February, 2014 by the United States Patent and Trademark Office.

‌
Mimetogen Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
8653036
February 18, 2014
‌
US Patent 9156882 Beta-turn peptidomimetic cyclic compounds for treating dry eye

Patent 9156882 was granted and assigned to Mimetogen Pharmaceuticals on October, 2015 by the United States Patent and Trademark Office.

‌
Mimetogen Pharmaceuticals
‌
Mimetogen Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
9156882
October 13, 2015
‌
US Patent 9115179 Synthesis of beta-turn peptidomimetic cyclic compounds

Patent 9115179 was granted and assigned to Mimetogen Pharmaceuticals on August, 2015 by the United States Patent and Trademark Office.

‌
Mimetogen Pharmaceuticals
‌
Mimetogen Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
9115179
August 25, 2015
‌
US Patent 8748391 β-turn peptidomimetic cyclic compounds for treating dry eye

‌
Mimetogen Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
8748391
June 10, 2014
‌
US Patent 8293713 Beta-turn peptidomimetic cyclic compounds for treating dry eye

Patent 8293713 was granted and assigned to Mimetogen Pharmaceuticals on October, 2012 by the United States Patent and Trademark Office.

‌
Mimetogen Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
8293713
October 23, 2012
‌
US Patent 11753441 Solution phase synthesis of beta-turn peptidomimetic cyclic salts

Patent 11753441 was granted and assigned to Mimetogen Pharmaceuticals on September, 2023 by the United States Patent and Trademark Office.

‌
Mimetogen Pharmaceuticals
‌
Mimetogen Pharmaceuticals
United States Patent and Trademark Office
United States Patent and Trademark Office
11753441
September 12, 2023
9 results
0 selected
9 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us